- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
Vasoactive Intestinal Polypeptide · Educational Resource
Understanding VIP and Neuroimmune Research
Vasoactive Intestinal Polypeptide
(Naturally Occurring Neuropeptide)
Investigational Application
Neuromodulatory, immune research
Administration Protocol
Intranasal, per study protocol
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →Vasoactive Intestinal Polypeptide · Educational Resource
Understanding VIP and Neuroimmune Research
01 — Overview
What is VIP?
Vasoactive Intestinal Polypeptide (VIP) is a naturally occurring neuropeptide, synthesized in laboratory settings for research purposes, distributed widely throughout the nervous, endocrine, and immune systems.
As an investigational compound for the specific research applications discussed here, VIP nasal spray has not received regulatory approval for these uses in the Philippines or elsewhere. It should be understood strictly as a research compound.
Within research literature, VIP is most frequently studied for its relationship to neuroimmune modulation and chronic inflammatory response research, areas summarized further below.
02 — How it works
How It Works: VPAC Receptor Signaling and Neuroimmune Modulation
As a neuropeptide, VIP is studied for its ability to bind VPAC1 and VPAC2 receptors, G-protein-coupled receptors distributed across neurons, immune cells, and smooth muscle tissue.
Literature describes this broad receptor distribution as the basis for VIP's studied roles spanning neuromodulation, immune regulation, and vascular tone, distinguishing it from more narrowly-targeted research peptides.
Administration in Research
In clinical and preclinical literature, VIP is evaluated as an intranasal spray administered within controlled research protocols. As an investigational compound for the applications studied here, research contexts differ from any at-home or self-directed use.
03 — Areas of research
Summary of Investigated Research Areas
Clinical and preclinical literature evaluates VIP across several key physiological parameters to map its biological interactions:
VPAC Receptor Signaling Pathways
Research literature evaluates how VIP binds to VPAC1 and VPAC2 receptors distributed throughout the nervous and immune systems.
Neuroimmune Modulation Studies
Preclinical studies observe neuroimmune marker changes following VIP administration in research models.
Circadian Rhythm Parameters
Investigational literature examines VIP's studied relationship to the suprachiasmatic nucleus and circadian rhythm regulation.
Chronic Inflammatory Response Research
Some literature investigates VIP's studied use in research related to chronic inflammatory response patterns associated with biotoxin exposure.
Pulmonary Function Studies
Studies explore VIP's studied relationship to pulmonary and vascular smooth muscle regulation.
Pharmacokinetic Profiling
Studies characterize the absorption profile of intranasal VIP in clinical research.
04 — FAQ
Frequently Asked Questions
05 — References
References and Academic Literature
Said, S.I., & Mutt, V. (1970). Polypeptide with Broad Biological Activity: Isolation from Small Intestine. Science.
Delgado, M., et al. (2004). Vasoactive Intestinal Peptide: The Dawn of a New Era in the Treatment of Immune Disorders. Current Pharmaceutical Design.
Gozes, I. (2001). Neuroprotective Peptides: Vasoactive Intestinal Peptide and Related Compounds Alleviate Injury by Direct and Astrocyte-Mediated Mechanisms. Journal of Molecular Neuroscience.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups
